Skip to main content
    N

    Natera Inc (NTRA)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $288.48
    -30.61 (-9.59%)

    Market Cap: $46.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Natera Inc (NTRA) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Natera (NTRA) trades at 14.3x sales and 22.2x book value. Its P/S of 14.3x is above its 5-year median of 9.6x.

    Current Multiples

    Its free cash flow yield is 0.1%.

    MultipleValue
    P/E (trailing)N/A
    Forward P/EN/A
    Price to sales14.3x
    Price to book22.2x
    Price to FCF792.1x
    EV/FCF773.6x
    PEGN/A
    FCF yield0.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 81.0% above 7.9x and its P/B is 39.6% above 15.9x.

    MultipleCurrent5-year median10-year median
    P/S14.3x9.6x7.9x
    P/B22.2x14.4x15.9x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 114 to 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 2.3x in 2017 to 20.3x in 2020.

    Year endPriceP/SP/B
    2025$229.0913.5x18.3x
    2024$158.3011.5x16.5x
    2023$62.646.7x9.8x
    2022$40.174.7x5.6x
    2021$93.3913.4x13.2x
    2020$99.5220.3x16.6x
    2019$33.697.8x9.5x
    2018$13.963.1x27.3x
    2017$8.992.3x19.1x
    2016$11.712.8x5.8x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About NTRA

    Is NTRA stock overvalued?

    GNG's valuation label for NTRA is Fairly valued.

    What is NTRA's price to sales ratio?

    Natera has a price to sales ratio of 14.3x.